Kangpu Biopharma receives China NMPA’s IND approval for KPG-818 to treat relapsed/refractory multiple myeloma: Hefei, China Saturday, March 1, 2025, 14:00 Hrs [IST] Kangpu Bioph ...

Shardul Nautiyal, Hyderabad Saturday, March 1, 2025, 08:00 Hrs [IST] ...

Akeso begins patient enrolment in phase I trial of AK138 D1 for the treatment of advanced malignancies in Australia: Hong Kong Saturday, March 1, 2025, 12:00 Hrs [IST] Akeso, Inc.

Planegg, Martinsried Saturday, March 1, 2025, 11:00 Hrs [IST] ...

Daiichi Sankyo announces establishment of upper limits for acquisition of own shares: Tokyo, Japan Saturday, March 1, 2025, 10:00 Hrs [IST] Daiichi Sankyo Company, Limited (hereaf ...

Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs ...

TN DCA to hold training programme for regulatory inspectorate on regulation of medical devices & filing of complaints: Peethaambaran Kunnathoor, Chennai Saturday, March 1, 2025, 0 ...

McKinsey report says Indian pharma rose to global prominence led by export boom & improved compliance: Shardul Nautiyal, Mumbai Saturday, March 1, 2025, 08:00 Hrs [IST] McKinsey & ...

The Central Drugs Standard Control Organisation (CDSCO) has announced that 145 drug samples tested across the country during the month of February 2025 have been identified as not of standard quality ...

NIMHANS’ multistate research project to fortify student mental health support systems in campuses: Nandita Vijayasimha, Bengaluru Saturday, March 1, 2025, 08:00 Hrs [IST] The Na ...

Dr Rajeev Singh Raghuvanshi has asked all the State Licensing Authorities (SLAs) to strengthen their state testing laboratories to conduct more tests, as the central laboratories are fully engaged in ...

Revelation Biosciences doses first patient in PRIME phase 1b study of Gemini in CKD patients: San Diego, California Friday, February 28, 2025, 18:00 Hrs [IST] Revelation Bioscienc ...